The treatment for uterine wall thickening is generally carried out using two main methods: hormone therapy or surgical intervention. The choice of treatment is determined individually based on various factors such as the presence of atypical cells, the patient's menopausal status, future pregnancy plans, and family history. In cases of simple (without atypia) endometrial hyperplasia, progestin, a synthetic form of progesterone, is administered as hormone therapy orally (pills), by injection, or via an intrauterine device (IUD). For atypical hyperplasia, hysterectomy (removal of the uterus) may be recommended, considering the high risk of cancer. While this surgical procedure significantly reduces the risk of cancer, it eliminates the possibility of natural pregnancy. Hysterectomy may be a suitable option, particularly for menopausal patients, those not planning future pregnancies, or individuals with a high risk of cancer.